Aim: Recently, there have been some reports on preoperative body mass index (BMI) and total cholesterol (TC) as a prognostic predictor for patients with renal cell carcinoma (RCC) but the topic is controversial and still poorly understood. So we analyzed the effects of BMI and TC on the prognosis of RCC.
INTRODUCTION
Incidence of renal cell carcinoma (RCC) is steadily increasing worldwide due to wide spread use of imaging studies. [1] [2] [3] The standard treatment of RCC is still nephrectomy. Postoperative patients are curious about the prognosis of their disease. Due to increasing early detection of RCC, exact treatment plan can give long life to patients. 1 Explaining prognosis and selecting individualized planning and the most appropriate treatment for each patient are very important nowadays.
Risk factors for RCC, including cigarette smoking, hypertension, chronic kidney failure, and obesity are thought to have negative effects on RCC prognosis. 4 However, many recent studies have shown a paradox that high body mass index (BMI) has a positive effect on RCC prognosis. 5, 6 It is known that high total cholesterol (TC) is associated with both obesity and metabolic syndrome. High TC is also a risk factor for various diseases, such as stroke, hypertension, and RCC. 7 However, high TC has also been found to be associated with better RCC prognosis. 3, 8 Interestingly, it has been reported that TC has different effects on various metabolic syndrome-related diseases according to gender. [9] [10] [11] Clifton et al. have reported that men and women respond differently to dietary fat and cholesterol. 12 Menopause also affects weight gain in e37 females. Therefore it has been suggested that BMI can affect men and women differently due to their differences in hormones. 13 Although there have been studies on effects of BMI, TC, and gender on RCC prognosis, results remain controversial. In addition, studies on the relationship between these factors are limited. 5, 6, [14] [15] [16] Therefore, the objective of this study was to determine the effect of BMI and TC on prognosis of RCC using multicenter cohort data of 7,047 RCC patients who had received partial or radical nephrectomy. These data were collected from Korean Renal Cell Carcinoma (KORCC) database. All data were analyzed to elucidate gender-and TC-specific predictive value of BMI in RCC patients. 17 
MATERIALS AND METHODS
Data from a total of 7,047 patients diagnosed with RCC, who underwent partial or radical nephrectomy and agreed to participate in KORCC study group between January 1999 and December 2015, were collected from eight tertiary care hospitals. All data were chart-based collected. Clinical data, such as age at operation, gen- and high (BMI ≥25 kg/m 2 ). All patients included in the study were then divided into four groups: (1) group 1, normal BMI with low TC; (2) group 2, high BMI with low TC; (3) group 3, normal BMI with high TC; and (4) group 4, high BMI with high TC. 
Statistical analysis

Ethical approval
This study was approved by the Institutional Review Board of Catholic University of Korea (Approval number: KC17REDI0584).
RESULTS
Overall characteristics divided by TC and BMI
Overall characteristics of 3,369 RCC patients treated with nehprectomy are summarized in Table 1 . Mean ages in Groups 1, 2, 3, and 4 were 57.70 ±13.31, 57.01 ± 12.62, 55.38 ± 12.68, and 54.40 ± 11.94 years, respectively. High-TC groups were diagnosed at earlier ages compared to low TC groups (P < 0.001). Mean BMI values in the four groups were 22.05 ± 2.02 kg/m 2 , 27.38 ± 2.11 kg/m 2 , 22.53 ± 1.85 kg/m 2 , and 27.44 ± 2.36 kg/m 2 , respectively (P < 0.001). Mean TC values of the four groups were 141.48 ± 15.37, 142.79 ± 16.02, 197.58 ± 31.87, and 202.89 ± 31.83 mg/dL, respectively (P < 0.001).
Mean tumor sizes of the four groups were 54.49 ± 51.18 mm, 47.81 ± 30.09 mm, 43.51 ± 38.23 mm, and 42.22 ± 29.66 mm, respectively (P < 0.001). Normal BMI with low TC group had the largest tumor size compared to other groups (P < 0.001). Proportions of incidental RCC in the four groups were 68.8%, 71.8%, 77.5%, and 81.0%, respectively (P < 0.001). Group 4 showed the highest rate of incidental diagnosis of RCC. Regarding TNM staging, group 4 also had the highest (P < 0.001) proportion of stage T1, the lowest (P < 0.001) proportion of T3-4, and the lowest (P < 0.001) proportion of N1 or M1 stage. However, there were no significant differences in proportion of stage T2 among groups. Based on the Fuhrman grading system, group 4 had the highest (P = 0.001) proportion of grade 1-2 but the lowest (P = 0.001) proportion of grade 3-4. Lymphovascular invasion was the lowest (P < 0.001) in group 4. From the aspect of histology, clear cell RCC was more (P = 0.001) frequently observed in group 4 ( Table 1) .
TA B L E 1
Clinical and pathologic characteristics of whole sample divided by level of preoperative body mass index (BMI) and total cholesterol (P Value means comparison between four groups using one-way ANOVA) 
Predictive value of TC-specific BMI for survival outcomes of RCC patients
Overall mean follow-up duration was 38.77 ± 32.50 months. Group 4 had the longest (P < 0.001) OS and the longest (P < 0.001) RFS compared to other groups ( Figure 1 ). For OS analysis, group 1 had the shortest OS compared to other groups (group 1 vs. group 2, P = 0.001; group 1 vs. group 3, P < 0.001; group 1 vs. group 4, P < 0.001). Group 1 also had the shortest RFS compared to other groups (group 1 vs. group 2, P = 0.035; group 1 vs. group 3, P < 0.001; group 1 vs. group 4, P < 0.001). However, OS or RFS was not significantly different between groups 2 and 3 (OS: P = 0.062; RFS: P = 0.126).
Predictive value of TC-specific BMI for survival outcomes of RCC patients by gender
In subgroup analysis, the four groups were divided by gender. In males, group 4 showed the longest (P < 0.001) OS and the longest (P < 0.001) RFS, similar to results for the whole sample. In females, results were different from those in males. Differences of OS were only shown in groups divided by TC, not shown in groups divided by BMI. There were no significant differences in OS between groups 1 and 2 or between groups 3 and 4 (P = 0.604, P = 0.795, respectively). Compared to group 1, groups 3 and 4 showed longer OS (P < 0.001, P = 0.001, respectively). Therefore, we analyzed the prognosis TC and BMI for female RCC patients separately. The effect of TC on the prognosis of female RCC patients was significant (P < 0.001), similar to that in males. However, BMI showed no significant association with OS or RFS in females (P = 0.650, P = 0.799, respectively, Figure 1 ).
Univariate and multivariate Cox regression analyses were performed to determine predictors for OS in each gender. In male groups, univariate Cox regression analysis showed high BMI and high TC increased OS (both P < 0.001) ( Table 2 In female groups, univariate Cox regression analysis showed that high TC increased OS (both P < 0.001), similar to results in male groups.
However, normal BMI or high BMI did not affect RCC prognosis (both P = 0.651). In multivariate analysis, however, high TC was not a significant prognostic factor for OS.
Correlation between BMI and incidental renal tumor incidence according to gender
To determine the relationship between BMI and incidental renal tumor in males and females, a linear-by-linear association was performed.
Males with normal BMI had lower incidental RCC compared to those with high BMI (74.8% vs. 80.0%, P = 0.003). However, incidental RCC rates were not significantly different between females with normal BMI and those with high BMI (74.2% vs. 74.3%, P = 0.971, Table 3 ). 
DISCUSSION
Similar to previous studies on BMI and TC, this study showed that high BMI and high TC had positive impacts on RCC prognosis. At the same time, high BMI and high TC might be risk factors for RCC. 3, 5, 6, 10, 15, [19] [20] [21] [22] Choi et al. have performed a metaanalysis on BMI and survival in RCC patients and found that high BMI prior to nephrectomy for RCC is associated with improved OS, CSS, and RFS. 6 The mechanism of high BMI as a prognostic factor is not well-known yet. Choi et al.
have suggested that better nutritional status might provide potential survival advantages. 6 They also suggested that obese patients might be more likely to be screened at an early stage of RCC compared to nonobese patients, which might influence survival rate. Lee 27 Their results
showed that high BMI was associated with clear cell histology and surgical morbidity. However, BMI did not impact or progression-free survival. They stratified OS and progression free survival (PFS) by gender and found that there were no significant differences between the two groups. 27 Therefore, further studies are needed to clarify the nature of this association.
Results of subgroup analysis divided by gender in the present study were similar to those of Ohno et al. 15 In males, group 4 showed significantly better prognosis for RCC compared to other groups, similar to results found in the whole sample. High TC was a good prognostic predictor for RCC in both male and female groups. On the other hand, high BMI was a significant prognosis predictor in male groups only. Beisland et al. have reported differences in incidental detection of CSS according to gender. 28 They analyzed 368 patients treated with nephrectomy for RCC and classified them according to detection mode (incidental or symptomatic disease). Their results showed that incidentally detected RCC group had earlier stage, smaller tumor size, and better CSS compared to symptomatic RCC group. Proportion of women was significantly higher in incidentally diagnosed RCC than that in symptomatic RCC. They concluded that women had lower threshold to symptoms with less resistance to see a physician compared to men and this also showed similar results in Korea 's statistical results (http://kosis.kr/index/index.do.). This might have contributed to women's more low stage at diagnosis and higher CSS than men.
We conducted another subgroup analysis to determine whether incidental diagnosis of RCC difference between men and women might be one reason that why BMI played a role in the prognosis of RCC in males only. Interestingly, there was a significant difference in incidental detection rate of RCC between males with normal BMI and males with high BMI, although such difference in females was not statistically significant. This indicates that males with high BMI might visit hospital more often due to like metabolic syndrome than normal BMI males.
Therefore, the probability of RCC screening at early stage is also higher in high BMI males than that in normal BMI males. On the other hand, females seem to visit hospitals more frequent even for mild symptoms regardless of their BMI status. The mechanism of difference in sexspecific predictive value of BMI in the RCC is not completely known yet. However, the difference in incidental detection rate between genders might contribute to such mechanism, at least to some extent.
This study has some weak points. First, this study had a retrospective design. Therefore, sampling bias might exist. In addition, this was a multicenter study. There might be some minor differences in surgical techniques, follow-up protocols, and adjuvant therapies. Second, we divided BMI into two groups. However, the Asian BMI criteria divided BMI into four groups. We defined cut-off value to only 25 kg/m 2 as a criterion for identifying trends and making the sample size of the two groups to be similar to avoid too large number of groups. Third, we analyzed incidental detection rates of RCC to explain why BMI had no predictive prognostic value in women with RCC. This can be one of causes of this association. However, it can be one of factors to be adjusted. Fourth, there was no control over factors that could affect TC, such as statin-based drugs. Many patients were expected to have artificially controlled TC. However, data on this matter could not be collected. This might have underestimated the survival outcome of the low-TC group who were taking lipid lowering agents. Some studies have suggested that lipid-lowering agents might improve RCC prognosis. Therefore, identifying patients with these agents seems to be necessary in the future to decrease bias. 29, 30 Finally, we could not obtain information on factors, such as muscle mass and waist circumference that might affect BMI. Since the effect of BMI differs according to individual human body composition, this information is also needed in the future to understand the mechanism of RCC prognosis.
Although many studies have shown that high BMI and high TC have favorable effects on the prognosis of RCC in patients who undergo nephrectomy, the mechanism remains unclear. Besides, gender differences for the impact of BMI on RCC prognosis have not been wellstudied. Several unknown factors may influence these findings. We analyzed incidental diagnosis of RCC in relation with BMI that was significantly different between males and females. Anyway, high BMI and high TC are related to metabolic syndrome, even though they are good prognostic factors for RCC. So active adjustment for this remains controversial, but it might be helpful for predicting the prognosis of patients with RCC.
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